MiMedx Group Cash Flow Statement
NASDAQ: MDXGHealth CareMedical/Dental InstrumentsUSD
4.67+0.05 (+1.08%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MiMedx Group free cash flow
In fiscal 2025, MiMedx Group generated $74.0 million of operating cash flow. That left free cash flow of $74.0 million, a free-cash-flow margin of 17.7% of revenue. Free cash flow was up 11.8% from the prior year's $66.2 million.
Summary generated from market data by MetaCap's automated system. Methodology
MiMedx Group cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 48.58M | 42.42M | 58.23M | -30.20M | -10.29M | -49.28M | -25.58M | -29.98M | 64.73M | 390.00K |
| Net Income growth (YoY) | +14.52% | -27.15% | — | — | — | — | — | -146.32% | +16496.67% | -98.68% |
| Depreciation & Amortization | 14.88M | 6.04M | 3.43M | 3.35M | 4.36M | 5.78M | 6.55M | 5.88M | 4.09M | 3.33M |
| Stock-Based Compensation | 16.40M | 16.93M | 16.96M | 11.33M | 14.16M | 15.36M | 12.06M | 14.77M | 21.20M | 17.73M |
| Change in Working Capital | -34.34M | -7.54M | -18.54M | -7.15M | -3.36M | -6.01M | -12.94M | 1.23M | 961.00K | -3.52M |
| Operating Cash Flow | 74.00M | 66.20M | 26.77M | -17.89M | -1.98M | -30.26M | -39.41M | 35.80M | 62.94M | 23.85M |
| Capital Expenditures | — | — | -1.99M | -1.51M | -3.22M | — | — | — | — | — |
| Investing Cash Flow | -6.89M | -9.58M | -2.15M | -2.66M | -3.40M | -4.55M | 504.00K | -9.22M | -5.40M | -11.68M |
| Share Repurchases | 0 | 0 | -9.52M | 0 | 0 | -900.00K | 0 | -7.60M | -68.30M | -10.40M |
| Financing Cash Flow | -5.41M | -34.20M | -8.57M | -580.00K | -3.35M | 61.56M | 62.86M | -8.93M | -60.39M | -8.15M |
| Net Change in Cash | 61.70M | 22.42M | 16.05M | -21.13M | -8.73M | 26.74M | 23.95M | 17.64M | -2.85M | 4.02M |
| Free Cash Flow | 74.00M | 66.20M | 24.79M | -19.41M | -5.20M | -30.26M | -39.41M | 35.80M | 62.94M | 23.85M |
This table shows 10 annual periods of MiMedx Group's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MDXG's reporting calendar. What is a cash flow statement?